Recombinant protein production in yeasts
- PMID: 22160907
- DOI: 10.1007/978-1-61779-433-9_17
Recombinant protein production in yeasts
Abstract
Recombinant protein production is a multibillion-dollar market. The development of a new product begins with the choice of a production host. While one single perfect host for every protein does not exist, several expression systems ranging from bacterial hosts to mammalian cells have been established. Among them, yeast cell factories combine the advantages of being single cells, such as fast growth and easy genetic manipulation, as well as eukaryotic features including a secretory pathway leading to correct protein processing and post-translational modifications. In this respect, especially the engineering of yeast glycosylation to produce glycoproteins of human-like glycan structures is of great interest. Additionally, different attempts of cellular engineering as well as the design of different production processes that are leading to improved productivities are presented. With the advent of cheaper next-generation sequencing techniques, systems biotechnology approaches focusing on genome scale analyses will advance and accelerate yeast cell factories and thus recombinant protein production processes in the near future. In this review we summarize advantages and limitations of the main and most promising yeast hosts, including Saccharomyces cerevisiae, Pichia pastoris, and Hansenula polymorpha as those presently used in large scale production of heterologous proteins.
Similar articles
-
Yeasts as a tool for heterologous gene expression.Methods Mol Biol. 2012;824:359-70. doi: 10.1007/978-1-61779-433-9_18. Methods Mol Biol. 2012. PMID: 22160908
-
Expression of heterologous proteins in Pichia pastoris: a useful experimental tool in protein engineering and production.J Mol Recognit. 2005 Mar-Apr;18(2):119-38. doi: 10.1002/jmr.687. J Mol Recognit. 2005. PMID: 15565717 Review.
-
Methylotrophic yeast hansenula polymorpha as production organism for recombinant pharmaceuticals.Arzneimittelforschung. 1996 Sep;46(9):943-8. Arzneimittelforschung. 1996. PMID: 8876947 Review.
-
Production of recombinant proteins by yeast cells.Biotechnol Adv. 2012 Sep-Oct;30(5):1108-18. doi: 10.1016/j.biotechadv.2011.09.011. Epub 2011 Sep 22. Biotechnol Adv. 2012. PMID: 21964262 Review.
-
Yeast synthetic biology for the production of recombinant therapeutic proteins.FEMS Yeast Res. 2015 Feb;15(1):1-16. doi: 10.1111/1567-1364.12195. Epub 2015 Jan 14. FEMS Yeast Res. 2015. PMID: 25130199
Cited by
-
Recent advances in the production of recombinant subunit vaccines in Pichia pastoris.Bioengineered. 2016 Apr;7(3):155-65. doi: 10.1080/21655979.2016.1191707. Bioengineered. 2016. PMID: 27246656 Free PMC article. Review.
-
Physiological response of Pichia pastoris GS115 to methanol-induced high level production of the Hepatitis B surface antigen: catabolic adaptation, stress responses, and autophagic processes.Microb Cell Fact. 2012 Aug 8;11:103. doi: 10.1186/1475-2859-11-103. Microb Cell Fact. 2012. PMID: 22873405 Free PMC article.
-
Lentiviral expression system for the purification of secreted proteins from human cell cultures.BMC Biotechnol. 2016 Sep 2;16(1):66. doi: 10.1186/s12896-016-0288-3. BMC Biotechnol. 2016. PMID: 27590008 Free PMC article.
-
Innovations in CAZyme gene diversity and its modification for biorefinery applications.Biotechnol Rep (Amst). 2020 Sep 1;28:e00525. doi: 10.1016/j.btre.2020.e00525. eCollection 2020 Dec. Biotechnol Rep (Amst). 2020. PMID: 32963975 Free PMC article. Review.
-
Yeast Secretes High Amounts of Human Calreticulin without Cellular Stress.Curr Issues Mol Biol. 2022 Apr 19;44(5):1768-1787. doi: 10.3390/cimb44050122. Curr Issues Mol Biol. 2022. PMID: 35678651 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases